170
Views
7
CrossRef citations to date
0
Altmetric
Review articles

Tobacco smoking within psychiatric inpatient settings: biopsychosocial perspective

, &
Pages 572-580 | Received 09 Nov 2006, Published online: 03 Aug 2009

References

  • Ridolfo, B, Stevenson, C.. The quantification of drug caused morbidity and mortality in Australia. Canberra: Australian Institute of Health and Welfare, 1998. Available from URL: http://www.aihw.gov.au/publications/phe/qdcmma98/.
  • Royal Australasian College of Physicians and the Royal Australian and New Zealand College of Psychiatrists. Tobacco policy: using evidence for better outcomes. Sydney: RACP and RANZCP, 2005.
  • Hughes JR. Possible effects of smoke-free inpatient units on psychiatric diagnosis and treatment. J Clin Psychiatry 1993; 54: 109–114
  • Ziedonis DM, George TP. Schizophrenia and nicotine use: report of a pilot smoking cessation program and review of neurobiological and clinical issues. Schizophr Bull 1997; 23: 247–254
  • Prochaska JJ, Fletcher L, Hall SE, Hall SM. Return to smoking following a smoke-free psychiatric hospitalization. Am J Addict 2006; 15: 15–22
  • Lawn S, Pols R. Nicotine withdrawal: pathway to aggression and assault in the locked psychiatric ward?. Australas Psychiatry 2003; 11: 199–203
  • Dickens G, Stubbs J, Popham R., Haw C. Smoking in a forensic psychiatric service: a survey of inpatients’ views. J Psychiatr Ment Health Nurs 2005; 12: 672–678
  • Gritz ER, Stapleton JM, Miller RR, Jaravik ME. Prevalence of cigarette smoking in VA medical and psychiatric hospitals. Bull Soc Psychol Addict Behav 1985; 4: 151–165
  • McDonald CA, Robert S, Descheemaeker N. Intentions to quit smoking in substance-abusing teens exposed to a tobacco program. J Subst Abuse Treat 2000; 18: 291–308
  • Fowles, J, Bates, M, Noiton, D. Chemical constituents in cigarettes and cigarette smoke: priorities for harm reduction. A report to the Ministry of Health. PoriruaNew Zealand: ESR, 2000.
  • US Department of Health and Human Services. Reducing the health consequences of smoking: 25 years of progress. A report of the Surgeon General. U.S. Department of Health and Human Services, Public Health Service, Centres for Disease Control, Centre for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 1989.
  • Brown S, Inskip H, Barraclough B. Causes of the excess mortality of schizophrenia. Br J Psychiatry 2000; 177: 212–217
  • Colton, CW, Manderscheid, RW. Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states. Prev Chronic Dis. 2006; 3: A42. [cited 27 Feb 2007]. Available from URL:, , http://www.cdc.gov/pcd/issues/2006/apr/05_0180.htm.
  • Pontieri FE, Tanda G, Orzi F, DiChiara G. Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Nature 1996; 382: 255–257
  • Clarke PB. Mesolimbic dopamine activation: the key to nicotine reinforcement?. Ciba Found Symp 1990; 152: 153–162
  • Leonard S, Breese C, Adams C, et al. Smoking and schizophrenia: abnormal nicotinic receptor expression. Eur J Pharmacol 2000; 393: 237–242
  • Patkar AA, Gopalakrishnan R, Lundy A, Leone FT, Certa KM, Weinstein SP. Relationship between tobacco smoking and positive and negative symptoms in schizophrenia. J Nerv Ment Dis 2002; 190: 604–610
  • Quattrocki, E, Baird, A, Yurgelun-Todd, X. Biological aspects of the link between smoking and depression. Harv Rev Psychiatry 2000; 8:99–110.
  • Fowler JS, Volkow ND, Wang GJ, et al. Inhibition of monoamine oxidase B in the brains of smokers. Nature 1996; 379: 733–736
  • American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th edn, text revision. Washington, DC: American Psychiatric Association, 2000.
  • Desai HD, Seabolt J, Jann MW. Smoking in patients receiving psychotropic medications. A pharmacokinetic perspective. CNS Drugs 2001; 15: 469–494
  • Tantcheva-Poor I, Zaigler M, Rietbrock S, Fuhr U. Estimation of cytochrome P-450 CYP1A2 activity in 863 healthy Caucasians using a saliva-based caffeine test. Pharmacogenetics 1999; 9: 131–144
  • Van Der Weide J, Steijns LS, Van Weelden MJ. The effect of smoking and cytochrome P450 CYP1A2 genetic polymorphism on clozapine clearance and dose requirement. Pharmacogenetics 2003; 13: 169–172
  • Miller LG. Recent developments in the study of the effects of cigarette smoking on clinical pharmacokinetics and clinical pharmacodynamics. Clin Pharmacokinet 1989; 17: 90–108
  • Greenwood-Smith C, Lubman DI, Castle DJ. Serum clozapine levels: a review of their clinical utility. J Psychopharmacol. 2003; 17: 234–238
  • Zullino DF, Delessert D, Eap CB, Preisig M, Baumann P. Tobacco and cannabis smoking cessation can lead to intoxication with clozapine or olanzapine. Int Clin Psychopharmacol 2002; 17: 141–143
  • Faber MS, Fuhr U. Time response of cytochrome P450 1A2 activity on cessation of heavy smoking. Clin Pharmacol Ther 2004; 76: 178–184
  • Lasser K, Boyd JW, Woolhandler S, Himmelstein DU, McCormick D, Bor DH. Smoking in mental illness: a population-based prevalence study. JAMA 2000; 284: 2606–2610
  • Prochaska JJ, Gill P, Hall SM. Treatment of tobacco use in an inpatient psychiatric setting. Psychiatr Serv 2004; 55: 1265–1270
  • Strand JE, Nyback H. Tobacco use in schizophrenia: a study of cotinine concentrations in the saliva of patients and controls. Eur Psychiatry 2005; 20: 50–54
  • Barnes M, Lawford BR, Burton SC, et al. Smoking and schizophrenia: is symptom profile related to smoking and which antipsychotic medication is of benefit in reducing cigarette use?. Aust N Z J Psychiatry 2006; 40: 575–580
  • Corvin A, O'Mahony E, O'Regan M, et al. Cigarette smoking and psychotic symptoms in bipolar affective disorder. Br J Psychiatry 2001; 179: 35–38
  • Glassman AH. Cigarette smoking: implications for psychiatric illness. Am J Psychiatry 1993; 150: 546–553
  • Isensee B, Wittchen HU, Stein MB, Höfler M, Lieb R. Smoking increases the risk of panic: findings from a prospective community study. Arch Gen Psychiatry 2003; 60: 692–700
  • Patton GC, Hibbert M, Rosier MJ, Carlin JB, Caust J, Bowes G. Is smoking associated with depression and anxiety in teenagers?. Am J Public Health 1996; 86: 225–230
  • Ostacher MJ, Nierenberg AA, Perlis RH, et al. The relationship between smoking and suicidal behavior, comorbidity, and course of illness in bipolar disorder. J Clin Psychiatry 2006; 67: 1907–1911
  • Peele R. Nicotine addiction in the psychiatric hospital: a preliminary report. Psychiatr J Univ Ott 1988; 4: 239
  • Resnick M, Bosworth EE. A survey of smoking policies in Oregon psychiatric facilities. Hosp Community Psychiatry 1988; 39: 313–315
  • Keizer I, Eytan A. Variations in smoking during hopitalization in psychiatric in-patient units and smoking prevalence in patients and health-care staff. Int J Soc Psychiatry 2005; 51: 317–328
  • Lawrie SM, Buckley LA, Ulyatt BC, et al. Cigarette smoking in psychiatric inpatients. J R Soc Med 1995; 88: 59
  • Strasser K, Moeller-Saxone K, Meadows G, Hocking B, Stanton J, Kee P. Smoking cessation in schizophrenia. General practice guidelines. Aust Fam Physician 2002; 31: 21–24
  • Chabrol H, Faury R, Mullet E, Callahan S, Weigelt A, Labrousse F. Study of nicotine dependence among 342 adolescents smokers. Arch Pediatr 2002; 7: 1064–1071
  • Mester R, Toren P, Ben-Moshe Y, Weizman A. Survey of smoking habits and attitudes of patients and staff in psychiatric hospitals. Psychopathology 1993; 26: 69–75
  • Addington J, El-Guebaly N, Addington D, Hodgins D. Readiness to stop smoking in schizophrenia. Can J Psychiatry 1997; 42: 49–52
  • Velicer WF, Fava JL, Prochaska JO, Abrams DB, Emmons KM, Pierce JP. Distribution of smokers by stage in three representative samples. Prev Med 1995; 24: 401–411
  • Carosella AM, Ossip-Klein DJ, Owens CA. Smoking attitudes, beliefs, and readiness to change among acute and long term care inpatients with psychiatric diagnoses. Addict Behav 1999; 24: 331–344
  • Irving LM, Seidner AL, Burling TA, Thomas RG, Brenner GF. Drug and alcohol abuse inpatients’ attitude about smoking cessation. J Subst Abuse 1994; 6: 267–278
  • Saxon AJ, McGuffin R, Walker RD. An open trial of transdermal nicotine replacement therapy for smoking cessation among alcohol- and drug-dependent inpatients. J Subst Abuse Treat 1997; 14: 333–337
  • Dore K, Hoey J. Smoking practices: knowledge and attitudes regarding smoking of university hospital nurses. Can J Public Health 1988; 79: 170–174
  • Tagliacozzo R, Vaughan S. Stress and smoking in hospital nurses. Am J Public Health 1982; 5: 441–448
  • Dickens GL, Stubbs JH, Haw CM. Smoking and mental health nurses: a survey of clinical staff in a psychiatric hospital. J Psychiatr Ment Health Nurs 2004; 11: 445–451
  • Buchanan CR, Huffman C, Barbour VM. Smoking health risks: counselling of psychiatric patients. J Psychosoc Nurs Ment Health Serv 1994; 32: 27–32
  • American Psychiatric Association. Practice guidelines for the treatment of patients with substance use disorders, 2nd edn. APA,. 2006. [Cited 27 Feb 2007] Available from URL:, , http://www.psych.org/psych_pract/treatg/pg/prac_guide.cfm
  • West R, Shiffman S. Effect of oral nicotine dosing forms on cigarette withdrawal symptoms and craving: a systematic review. Psychopharmacology 2001; 155: 115–122
  • D'Mello DA, Bandlamudi GR, Colenda CC. Nicotine replacement methods on a psychiatric unit. Am J Drug Alcohol Abuse 2001; 27: 525–529
  • Palmer KJ, Buckley MM, Faulds D. Transdermal nicotine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy as an aid to smoking cessation. Drugs 1992; 44: 498–529
  • Kornitzer M, Boutsen M, Dramaix M, Thijs J, Gustavsson G. Combined use of nicotine patch and gum in smoking cessation: a placebo-controlled clinical trial. Prev Med 1995; 24: 41–47
  • Bohadana A, Nilsson F, Rasmussen T, Martinet Y. Nicotine inhaler and nicotine patch as a combination therapy for smoking cessation: a randomized, double-blind, placebo controlled trial. Arch Intern Med 2000; 160: 3128–3134
  • Shiffman S, Dresler CM, Hajek P, Gilburt SJ, Targett DA, Strahs KR. Efficacy of a nicotine lozenge for smoking cessation. Arch Intern Med 2002; 162: 1267–1276
  • Addington J, El-Guebaly N, Campbell W, Hodgins DC, Addington D. Smoking cessation treatment for patients with schizophrenia. Am J Psychiatry 1998; 155: 974–976
  • George TP, Ziedonis DM, Feingold A, et al. Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia. Am J Psychiatry 2000; 157: 1835–1842
  • Hurt RD, Sachs DP, Glover ED, et al. A comparison of sustained-release bupropion and placebo for smoking cessation. N Engl J Med 1997; 337: 1195–1202
  • Hughes, J, Stead, L, Lancaster, T. Antidepressants for smoking cessation. Cochrane Database Syst Rev 2004; CD000031.
  • West R. Helping patients in hospital to quit smoking. BMJ 2002; 324: 64
  • Rigotti, NA, Munafo, MR, Murphy, MF, Stead, LF. Interventions for smoking cessation in hospitalised patients. Cochrane Database of Syst Rev 2003; CD001837.
  • Taylor CB, Miller NH, Cameron RP, Fagans EW, Das S. Dissemination of an effective inpatient tobacco use cessation program. Nicotine Tob Res 2005; 7: 129–137
  • Baker A, Richmond R, Haile M, et al. A randomized controlled trial of a smoking cessation intervention among people with a psychotic disorder. Am J Psychiatry 2006; 163: 1934–1942
  • Washington A, Moll S, Pawlick J, et al. Smokebusters: an approach to help people with a mental illness move closer to a smoke-free lifestyle. Community Social and Vocational Rehabilitation Foundation, Hamilton, Ontario 1997
  • Lawn S, Pols R. Smoking bans in psychiatric inpatient settings? A review of the research. Aust N Z J Psychiatry 2005; 39: 866–885
  • El-Guebaly N, Cathcart J, Currie S, Brown D, Gloster S. Public health and therapeutic aspects of smoking bans in mental health and addiction settings. Psychiatr Serv 2002; 53: 1617–1622
  • Greeman M, McClellan TA. Negative effects of a smoking ban on an inpatient psychiatry service. Hosp Community Psychiatry 1991; 42: 408–412
  • Velasco J, Eels TD, Anderson R, et al. A two year follow-up on the effects of a smoking ban in an inpatient psychiatric service. Psychiatr Serv 1996; 47: 869–871
  • Killen JD, Fortmann SP, Schatzberg A, Hayward C, Varady A. Onset of major depression during treatment for nicotine dependence. Addict Behav 2003; 28: 461–470
  • McNeill, A. Smoking and mental health: a review of the literature. Report for SmokeFree London programme. London: SmokeFree London Programme. 2001.
  • Lavin M. Let the patients smoke: a defence of a patient privilege. J Med Ethics 1990; 16: 136–140
  • Bloch M, Shopland DR. Outdoor smoking bans: more than meets the eye. Tobacco Control 2000; 9: 99

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.